INTRODUCTION: Factors regulating brain tissue plasminogen activator (tPA) are pertinent for stroke. Recent observations have suggested a role for the phosphodiesterase-4 (PDE4) pathway in stroke pathogenesis, via an uncertain mechanism. We studied PDE4 regulation of tPA expression by human brain microvascular endothelial cells in a variety of conditions, including an in vitro model of ischemia. MATERIALS AND METHODS: We analyzed tPA antigen and mRNA of human brain microvascular endothelial cells (HBECs) during normoxia and oxygen-glucose deprivation (OGD) following inhibition of PDE4 and PDE4D, using HBEC monocultures and co-cultures with astrocytes and pericytes, and analyzed relevant signal transduction pathways. RESULTS: PDE4 inhibitor rolipram enhanced OGD effects on endothelial tPA release in endothelial monocultures and co-cultures with astrocytes; there was a 54±10% (p<0.001) reduction of tPA release in astrocyte-endothelial co-cultures under OGD. PDE4D siRNA reduced endothelial tPA mRNA to 40-55% of control (p<0.05). Use of Epac inducer mimicked, while use of Epac siRNA inhibited, these effects. CONCLUSIONS: Inhibition of PDE4 and PDE4D reduced expression of tPA by HBEC via Epac pathway.
INTRODUCTION: Factors regulating brain tissue plasminogen activator (tPA) are pertinent for stroke. Recent observations have suggested a role for the phosphodiesterase-4 (PDE4) pathway in stroke pathogenesis, via an uncertain mechanism. We studied PDE4 regulation of tPA expression by human brain microvascular endothelial cells in a variety of conditions, including an in vitro model of ischemia. MATERIALS AND METHODS: We analyzed tPA antigen and mRNA of human brain microvascular endothelial cells (HBECs) during normoxia and oxygen-glucose deprivation (OGD) following inhibition of PDE4 and PDE4D, using HBEC monocultures and co-cultures with astrocytes and pericytes, and analyzed relevant signal transduction pathways. RESULTS:PDE4 inhibitor rolipram enhanced OGD effects on endothelial tPA release in endothelial monocultures and co-cultures with astrocytes; there was a 54±10% (p<0.001) reduction of tPA release in astrocyte-endothelial co-cultures under OGD. PDE4D siRNA reduced endothelial tPA mRNA to 40-55% of control (p<0.05). Use of Epac inducer mimicked, while use of Epac siRNA inhibited, these effects. CONCLUSIONS: Inhibition of PDE4 and PDE4D reduced expression of tPA by HBEC via Epac pathway.
Authors: R F Macko; S F Ameriso; A Gruber; J H Griffin; J A Fernandez; R Barndt; F P Quismorio; J M Weiner; M Fisher Journal: Stroke Date: 1996-11 Impact factor: 7.914
Authors: Dong Hyung Lee; Hye Rin Lee; Hwa Kyoung Shin; So Youn Park; Ki Whan Hong; Eun Kyoung Kim; Sun Sik Bae; Won Suk Lee; Byung Yong Rhim; Chi Dae Kim Journal: J Neurosci Res Date: 2011-02-17 Impact factor: 4.164
Authors: L L Rubin; D E Hall; S Porter; K Barbu; C Cannon; H C Horner; M Janatpour; C W Liaw; K Manning; J Morales Journal: J Cell Biol Date: 1991-12 Impact factor: 10.539
Authors: Bin Gong; Thomas Shelite; Fang C Mei; Tuha Ha; Yaohua Hu; Guang Xu; Qing Chang; Maki Wakamiya; Thomas G Ksiazek; Paul J Boor; Donald H Bouyer; Vsevolod L Popov; Ju Chen; David H Walker; Xiaodong Cheng Journal: Proc Natl Acad Sci U S A Date: 2013-11-11 Impact factor: 11.205
Authors: Yi Na Dong; Clementina Mesaros; Peining Xu; Elizabeth Mercado-Ayón; Sarah Halawani; Lucie Vanessa Ngaba; Nathan Warren; Patrick Sleiman; Layne N Rodden; Kimberly A Schadt; Ian A Blair; David R Lynch Journal: PNAS Nexus Date: 2022-07-26